India's Tatva Chintan Pharma Chem soars on Q1 profit jump

Tatva Chintan Pharma Chem

25/07/2025 06:08

** Tatva Chintan Pharma Chem TATV.NS soars as much as 20% to 1,218.5 rupees, highest since June 21, 2024

** Chemical manufacturer reports 27.7% y/y rise in Q1 net profit; rev grows 10.8%

** Q1 EBITDA margin at 14.8% vs year-ago 12%

** Stock set to gain for 2nd week, up 1.5% so far this week

** Stock logs busiest session since listing on July 29, 2021, with more than 2.2 mln shares traded, 20.2x the 30-day moving avg

** Stock rated "buy" on avg; median PT is 820 rupees, per data compiled by LSEG

** TATV last up 17.7%, taking YTD gains to 14.2%

 (Reporting by Meenakshi Maidas in Bengaluru)

 ((meenakshi.maidas@thomsonreuters.com;))